Budget Express 2026

co-presented by

  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Budget Express 2026

co-presented by

  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jan 29, 16:01
1589.30 -20.85 (-1.29%)
Volume
AVERAGE VOLUME
5-Day
120,928
10-Day
237,821
30-Day
148,797
113,632
  • Prev. Close

    1610.15

  • Open Price

    1612.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 29, 15:59
1589.30 -21.30 (-1.32%)
Volume
AVERAGE VOLUME
5-Day
2,939,462
10-Day
3,063,910
30-Day
2,290,474
5,796,513
  • Prev. Close

    1610.60

  • Open Price

    1625.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1589.30 (132)

Company Facts - Sun Pharma

Registered Address

Sun Pharma Advanced Research Centre (SPA
Tandalja,,
Vadodra
Gujarat
390012

Tel: 0265-6615500 0265-6615600
Fax: 0265-2354897
Email: secretarial@sunpharma.com
Website: http://www.sunpharma.com
Group:

Registrars

MUFG Intime India Pvt. Ltd. C 101, 247 Park, L.B.S. Marg, Vikhroli (West),
Mumbai - 400083
Maharashtra

Tel: 022-49186270, 49186200
Fax: 022-49186060
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Sun Pharma

NameDesignation
Dilip S Shanghvi Chairman & Managing Director
Vidhi D Shanghvi Whole Time Director
Pawan Goenka Lead Independent Director
Gautam Doshi Independent Director
NameDesignation
Aalok D Shanghvi Whole Time Director & COO
Sudhir V Valia Non Exe.Non Ind.Director
Rama Bijapurkar Independent Director
Rolf Hoffmann Independent Director
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347